Cynthia Schwalm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cynthia schwalm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cynthia Schwalm Today - Breaking & Trending Today

Investegate |Hikma Pharmaceutical Announcements | Hikma Pharmaceutical: Result of AGM


A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
1. Obtains access to the information in a personal capacity;
2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....

United Arab Emirates , United States , United Kingdom , City Of , Peter Speirs , Cynthia Schwalm , Susan Ringdal , Pamela Kirby , Ali Al Husry , Siggi Olafsson , John Castellani , Nina Henderson , Patrick Butler , Mazen Darwazah , Hikma Pharmaceuticals , Global Affairs , National Storage Mechanism , Audit Committee , Annual General Meeting , Burlington Place , Submission System , National Storage , Ordinary Shares , Douglas Hurt , Said Darwazah , Jordanian Dinar ,

Nanoform 1-12/2020 report and new company near-term target introduced


Nanoform 1-12/2020 report and new company near-term target introduced
Nanoform
Company Announcement
Nanoform 1-12/2020 report and new company near-term target introduced
First GMP manufacturing campaign and first dosing in humans successfully completed, positive interim results from first clinical study announced, all near-term business targets set out in IPO achieved, ten new Small Molecule PoC projects started, four more non-GMP lines commissioned, first Biologics PoC project commenced and a new near-term business target introduced: “At least 3 new non-GMP lines in 2021 and 2 new GMP lines in 2022”.
10-12/2020 key financials:
- Revenue was EUR 186 thousand (EUR 49 thousand in 10-12/2019).
- The gross profit and margin came in at EUR 135 thousand and 73%, during 10-12/2019 the gross profit was negative. ....

Eteläuomen Läi , United States , United Kingdom , April Nanoform , Johanna Tuomisto , Eric Peter , Miguel Calado , July Nanoform , Biologics Po , Sergie Letser , Christian Jones , Cynthia Schwalm , June Nanoform , Finnish Financial Supervisory Authority , Finnish Medicines Agency , Finland Branch , Orion Corporation , Nanoform United States Inc , Danske Bank , Coast Us Biotech Company , Nanoform Finland Plc , Herantis Pharma Plc , Company Announcement , Small Molecule Poc , Biologics Poc , January Nanoform United States ,